Previous reports suggest that cerebrospinal fluid tau in patients with AD and patients with mild cognitive impairment comprises primarily truncated forms of tau (151–391/2N4R, sequence corresponding to full-length 2N4R tau), which are conformationally different from normal healthy tau and essential for pathologic tau-tau interaction [8–10]. The gene discussed is MAPT; the disease is Cognitive impairment.